

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cilium or flagellum-dependent cell motility (GO:0001539) | 9.21905608 |
| 2 | cilium movement (GO:0003341) | 8.78633283 |
| 3 | motile cilium assembly (GO:0044458) | 8.49261275 |
| 4 | epithelial cilium movement (GO:0003351) | 7.66594727 |
| 5 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 7.35534773 |
| 6 | axoneme assembly (GO:0035082) | 5.87825092 |
| 7 | left/right pattern formation (GO:0060972) | 5.82905257 |
| 8 | primary alcohol catabolic process (GO:0034310) | 5.54978881 |
| 9 | regulation of cilium movement (GO:0003352) | 5.20455262 |
| 10 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.74631624 |
| 11 | ethanol metabolic process (GO:0006067) | 4.47927731 |
| 12 | reactive oxygen species biosynthetic process (GO:1903409) | 4.27286198 |
| 13 | protein maturation by protein folding (GO:0022417) | 4.19662400 |
| 14 | diterpenoid biosynthetic process (GO:0016102) | 4.16816373 |
| 15 | vitamin transmembrane transport (GO:0035461) | 4.14736709 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.09703626 |
| 17 | respiratory burst (GO:0045730) | 4.09344932 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 3.99399235 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 3.99399235 |
| 20 | response to peptidoglycan (GO:0032494) | 3.98690705 |
| 21 | superoxide anion generation (GO:0042554) | 3.95973612 |
| 22 | urate metabolic process (GO:0046415) | 3.78850403 |
| 23 | microtubule bundle formation (GO:0001578) | 3.69286861 |
| 24 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.66934244 |
| 25 | intraciliary transport (GO:0042073) | 3.66800972 |
| 26 | aldehyde catabolic process (GO:0046185) | 3.65922309 |
| 27 | terpenoid biosynthetic process (GO:0016114) | 3.65279577 |
| 28 | lysine metabolic process (GO:0006553) | 3.61247515 |
| 29 | lysine catabolic process (GO:0006554) | 3.61247515 |
| 30 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.59769856 |
| 31 | phagosome maturation (GO:0090382) | 3.58675543 |
| 32 | GDP-mannose metabolic process (GO:0019673) | 3.58586930 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.56666398 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.56666398 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 3.56666398 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.56666398 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 3.56666398 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.56666398 |
| 39 | glutathione derivative biosynthetic process (GO:1901687) | 3.53112311 |
| 40 | glutathione derivative metabolic process (GO:1901685) | 3.53112311 |
| 41 | left/right axis specification (GO:0070986) | 3.49571184 |
| 42 | lung epithelium development (GO:0060428) | 3.49380364 |
| 43 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.48260092 |
| 44 | ethanol oxidation (GO:0006069) | 3.47041069 |
| 45 | electron transport chain (GO:0022900) | 3.45353858 |
| 46 | regulation of autophagic vacuole assembly (GO:2000785) | 3.44784984 |
| 47 | respiratory electron transport chain (GO:0022904) | 3.40925922 |
| 48 | regulation of microtubule-based movement (GO:0060632) | 3.40829664 |
| 49 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.40084515 |
| 50 | response to xenobiotic stimulus (GO:0009410) | 3.34907877 |
| 51 | sperm capacitation (GO:0048240) | 3.30519875 |
| 52 | ventricular system development (GO:0021591) | 3.30027265 |
| 53 | drug transmembrane transport (GO:0006855) | 3.28870625 |
| 54 | one-carbon compound transport (GO:0019755) | 3.26762936 |
| 55 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.25417583 |
| 56 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.20686571 |
| 57 | establishment of apical/basal cell polarity (GO:0035089) | 3.18026603 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.10733564 |
| 59 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.08847214 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.08175098 |
| 61 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.04338404 |
| 62 | cilium organization (GO:0044782) | 3.03847833 |
| 63 | GTP biosynthetic process (GO:0006183) | 3.03544550 |
| 64 | glyoxylate metabolic process (GO:0046487) | 3.01303382 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.00304499 |
| 66 | drug transport (GO:0015893) | 2.99722647 |
| 67 | glutathione metabolic process (GO:0006749) | 2.99271864 |
| 68 | cilium assembly (GO:0042384) | 2.98568902 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.97570463 |
| 70 | protein localization to cilium (GO:0061512) | 2.95791675 |
| 71 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.94520864 |
| 72 | ATP synthesis coupled proton transport (GO:0015986) | 2.94520864 |
| 73 | regulation of vacuole organization (GO:0044088) | 2.94260014 |
| 74 | * hydrogen peroxide catabolic process (GO:0042744) | 2.89983590 |
| 75 | primary alcohol metabolic process (GO:0034308) | 2.86089120 |
| 76 | organic cation transport (GO:0015695) | 2.84837345 |
| 77 | protein retention in ER lumen (GO:0006621) | 2.83964173 |
| 78 | indole-containing compound catabolic process (GO:0042436) | 2.83232980 |
| 79 | indolalkylamine catabolic process (GO:0046218) | 2.83232980 |
| 80 | tryptophan catabolic process (GO:0006569) | 2.83232980 |
| 81 | retinoic acid metabolic process (GO:0042573) | 2.82325998 |
| 82 | protein insertion into membrane (GO:0051205) | 2.81642349 |
| 83 | granulocyte activation (GO:0036230) | 2.81261560 |
| 84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79419593 |
| 85 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.78856955 |
| 86 | nucleoside diphosphate metabolic process (GO:0009132) | 2.78556374 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78313838 |
| 88 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.77672003 |
| 89 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.77672003 |
| 90 | positive regulation of heat generation (GO:0031652) | 2.77377845 |
| 91 | cysteine metabolic process (GO:0006534) | 2.77058232 |
| 92 | regulation of chemokine biosynthetic process (GO:0045073) | 2.75724994 |
| 93 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.74178605 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 2.73370391 |
| 95 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73340555 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.72397240 |
| 97 | response to host immune response (GO:0052572) | 2.72397240 |
| 98 | 2-oxoglutarate metabolic process (GO:0006103) | 2.70903789 |
| 99 | aromatic amino acid family catabolic process (GO:0009074) | 2.70442456 |
| 100 | positive regulation of mast cell degranulation (GO:0043306) | 2.70422575 |
| 101 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.70422575 |
| 102 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.70110391 |
| 103 | leukocyte aggregation (GO:0070486) | 2.70025711 |
| 104 | establishment of monopolar cell polarity (GO:0061162) | 2.69512490 |
| 105 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.69512490 |
| 106 | desmosome organization (GO:0002934) | 2.67716111 |
| 107 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.67688336 |
| 108 | glomerular epithelial cell development (GO:0072310) | 2.66637129 |
| 109 | tryptophan metabolic process (GO:0006568) | 2.66310669 |
| 110 | microtubule-based movement (GO:0007018) | 2.66012390 |
| 111 | kynurenine metabolic process (GO:0070189) | 2.65131846 |
| 112 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.64899778 |
| 113 | oligosaccharide biosynthetic process (GO:0009312) | 2.64723229 |
| 114 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.63996822 |
| 115 | UTP biosynthetic process (GO:0006228) | 2.63370816 |
| 116 | retinol metabolic process (GO:0042572) | 2.62943624 |
| 117 | multicellular organismal water homeostasis (GO:0050891) | 2.62398628 |
| 118 | positive regulation of interferon-alpha production (GO:0032727) | 2.62149836 |
| 119 | regulation of fever generation (GO:0031620) | 2.59457670 |
| 120 | lipoxygenase pathway (GO:0019372) | 2.56962578 |
| 121 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.56551643 |
| 122 | L-phenylalanine metabolic process (GO:0006558) | 2.56551643 |
| 123 | regulation of metalloenzyme activity (GO:0048552) | 2.56461210 |
| 124 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.56255062 |
| 125 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.55959112 |
| 126 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.55893476 |
| 127 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.54457841 |
| 128 | L-phenylalanine catabolic process (GO:0006559) | 2.54457841 |
| 129 | tricarboxylic acid metabolic process (GO:0072350) | 2.54412891 |
| 130 | response to manganese ion (GO:0010042) | 2.54176269 |
| 131 | neutrophil activation (GO:0042119) | 2.52732808 |
| 132 | L-ascorbic acid metabolic process (GO:0019852) | 2.51861874 |
| 133 | response to mercury ion (GO:0046689) | 2.51461036 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 2.51195733 |
| 135 | proline biosynthetic process (GO:0006561) | 2.50881873 |
| 136 | regulation of interleukin-5 production (GO:0032674) | 2.49893124 |
| 137 | NADH metabolic process (GO:0006734) | 2.49872623 |
| 138 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.49300687 |
| 139 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.49202695 |
| 140 | regulation of interleukin-13 production (GO:0032656) | 2.48883870 |
| 141 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.48493409 |
| 142 | nucleotide phosphorylation (GO:0046939) | 2.48402499 |
| 143 | glutathione biosynthetic process (GO:0006750) | 2.48371276 |
| 144 | fatty acid beta-oxidation (GO:0006635) | 2.48312286 |
| 145 | amino-acid betaine metabolic process (GO:0006577) | 2.48254068 |
| 146 | extracellular fibril organization (GO:0043206) | 2.47922511 |
| 147 | leukotriene metabolic process (GO:0006691) | 2.47292769 |
| 148 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.46710698 |
| 149 | UTP metabolic process (GO:0046051) | 2.46197288 |
| 150 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.45432792 |
| 151 | drug catabolic process (GO:0042737) | 2.45018802 |
| 152 | aspartate family amino acid catabolic process (GO:0009068) | 2.44776941 |
| 153 | regulation of interferon-alpha production (GO:0032647) | 2.44704906 |
| 154 | detection of molecule of bacterial origin (GO:0032490) | 2.43400904 |
| 155 | positive regulation of mast cell activation (GO:0033005) | 2.43130676 |
| 156 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.42995934 |
| 157 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.42899821 |
| 158 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.42741250 |
| 159 | hydrogen ion transmembrane transport (GO:1902600) | 2.41996549 |
| 160 | regulation of cholesterol storage (GO:0010885) | 2.41573410 |
| 161 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.41564861 |
| 162 | valine metabolic process (GO:0006573) | 2.39420177 |
| 163 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.39166702 |
| 164 | cellular aldehyde metabolic process (GO:0006081) | 2.39087087 |
| 165 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.38274279 |
| 166 | short-chain fatty acid metabolic process (GO:0046459) | 2.37733115 |
| 167 | oxidative phosphorylation (GO:0006119) | 2.37691325 |
| 168 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.37502016 |
| 169 | detection of other organism (GO:0098543) | 2.37208775 |
| 170 | carnitine metabolic process (GO:0009437) | 2.37115338 |
| 171 | exogenous drug catabolic process (GO:0042738) | 2.36954926 |
| 172 | lipid oxidation (GO:0034440) | 2.36420120 |
| 173 | polyketide metabolic process (GO:0030638) | 2.35383830 |
| 174 | doxorubicin metabolic process (GO:0044598) | 2.35383830 |
| 175 | daunorubicin metabolic process (GO:0044597) | 2.35383830 |
| 176 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.35182530 |
| 177 | plasma lipoprotein particle clearance (GO:0034381) | 2.34843872 |
| 178 | response to host (GO:0075136) | 2.34662866 |
| 179 | response to host defenses (GO:0052200) | 2.34662866 |
| 180 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.34662866 |
| 181 | amyloid precursor protein catabolic process (GO:0042987) | 2.34643693 |
| 182 | cytoplasmic microtubule organization (GO:0031122) | 2.34406743 |
| 183 | cellular response to zinc ion (GO:0071294) | 2.33619972 |
| 184 | fatty acid oxidation (GO:0019395) | 2.33361535 |
| 185 | positive regulation of leukocyte degranulation (GO:0043302) | 2.33322742 |
| 186 | oxaloacetate metabolic process (GO:0006107) | 2.32812486 |
| 187 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.32081541 |
| 188 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.32081541 |
| 189 | homocysteine metabolic process (GO:0050667) | 2.32069407 |
| 190 | quaternary ammonium group transport (GO:0015697) | 2.32068559 |
| 191 | * hydrogen peroxide metabolic process (GO:0042743) | 2.31420028 |
| 192 | tricarboxylic acid cycle (GO:0006099) | 2.28961455 |
| 193 | axonemal dynein complex assembly (GO:0070286) | 12.9528935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.44231705 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.68456221 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47272776 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.44772325 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.19014617 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.12136528 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.33484195 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.07846585 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.95709066 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.92962137 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79264883 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.69783198 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67185068 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61726939 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.52160082 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42648879 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.38666765 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.37564528 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29570178 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.28577999 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.22341975 |
| 22 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.22077480 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.13956499 |
| 24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.11546875 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10818738 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.10495295 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09569026 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05635411 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02770136 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.00299013 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.94800270 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.85999594 |
| 33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.83869055 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76493146 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.75100134 |
| 36 | P68_20966046_ChIP-Seq_HELA_Human | 1.74543131 |
| 37 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72240916 |
| 38 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.71295250 |
| 39 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.71016684 |
| 40 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.70226280 |
| 41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63488981 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56861263 |
| 43 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.56587484 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.55180319 |
| 45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.54321303 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.52667460 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42452852 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42115718 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41410327 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.41390885 |
| 51 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.39127989 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38938165 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38618850 |
| 54 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.38528110 |
| 55 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.37669475 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37485696 |
| 57 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.36403472 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36297963 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34102140 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33064780 |
| 61 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.32569814 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31957277 |
| 63 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.30902532 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30280277 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30280277 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30213386 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29646087 |
| 68 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.29303074 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29265563 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28941987 |
| 71 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.28804598 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27837855 |
| 73 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26784644 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25479989 |
| 75 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.24489714 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23026259 |
| 77 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22199944 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22037394 |
| 79 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.21510061 |
| 80 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21126168 |
| 81 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20786010 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20741676 |
| 83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20524621 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20449597 |
| 85 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19643318 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19601455 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18928211 |
| 88 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.17748606 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17742485 |
| 90 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.16920687 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16469228 |
| 92 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16041673 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15930317 |
| 94 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15879199 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15696513 |
| 96 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.14971433 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14531397 |
| 98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14411402 |
| 99 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14218497 |
| 100 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12354500 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11505348 |
| 102 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11065566 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11015944 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10875051 |
| 105 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.10252481 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09964017 |
| 107 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.09510519 |
| 108 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08239935 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07445415 |
| 110 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06848553 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06182006 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05153783 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04976807 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04119886 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03397972 |
| 116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02291003 |
| 117 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01779359 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01707112 |
| 119 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01561412 |
| 120 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01482090 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01428737 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00760619 |
| 123 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99702217 |
| 124 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.98412753 |
| 125 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97789281 |
| 126 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.97772718 |
| 127 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.97525319 |
| 128 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.97330986 |
| 129 | P300_27268052_Chip-Seq_Bcells_Human | 0.96956347 |
| 130 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96454097 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96178932 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95449376 |
| 133 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95378150 |
| 134 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95339127 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93535744 |
| 136 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93499168 |
| 137 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92901266 |
| 138 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92861772 |
| 139 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.91449380 |
| 140 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91431156 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90345156 |
| 142 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.88388173 |
| 143 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87591031 |
| 144 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86671524 |
| 145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84940618 |
| 146 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83038343 |
| 147 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.79803374 |
| 148 | SPI1_23127762_ChIP-Seq_K562_Human | 0.79338081 |
| 149 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78554915 |
| 150 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78469814 |
| 151 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78210271 |
| 152 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77843913 |
| 153 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76437845 |
| 154 | CJUN_26792858_Chip-Seq_BT549_Human | 0.75892119 |
| 155 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73266845 |
| 156 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71942208 |
| 157 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71620101 |
| 158 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.71511423 |
| 159 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70509782 |
| 160 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.70251223 |
| 161 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69392193 |
| 162 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68392948 |
| 163 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66922764 |
| 164 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66675083 |
| 165 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.65926908 |
| 166 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.65248245 |
| 167 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.64581210 |
| 168 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.64463072 |
| 169 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.63492913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 4.57979948 |
| 2 | MP0005360_urolithiasis | 4.13768943 |
| 3 | MP0003195_calcinosis | 3.43013781 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 3.37105419 |
| 5 | MP0002132_abnormal_respiratory_system | 3.35155798 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.28039609 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 3.28037422 |
| 8 | MP0001984_abnormal_olfaction | 3.09573630 |
| 9 | MP0003436_decreased_susceptibility_to | 3.08403362 |
| 10 | MP0009785_altered_susceptibility_to | 2.86194912 |
| 11 | MP0003724_increased_susceptibility_to | 2.65199588 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.64710056 |
| 13 | MP0008789_abnormal_olfactory_epithelium | 2.55864866 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.47872735 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.41565986 |
| 16 | MP0003646_muscle_fatigue | 2.39899235 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.39315974 |
| 18 | MP0005332_abnormal_amino_acid | 2.39250398 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.36879499 |
| 20 | MP0004043_abnormal_pH_regulation | 2.31441742 |
| 21 | MP0000566_synostosis | 2.25574864 |
| 22 | MP0004133_heterotaxia | 2.24116006 |
| 23 | MP0002419_abnormal_innate_immunity | 2.23514578 |
| 24 | MP0005623_abnormal_meninges_morphology | 2.23098645 |
| 25 | MP0006082_CNS_inflammation | 2.16212990 |
| 26 | MP0009764_decreased_sensitivity_to | 2.14721542 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.13112502 |
| 28 | MP0003186_abnormal_redox_activity | 2.08662099 |
| 29 | MP0003303_peritoneal_inflammation | 2.08361724 |
| 30 | MP0010030_abnormal_orbit_morphology | 2.03288127 |
| 31 | MP0005025_abnormal_response_to | 2.01814588 |
| 32 | MP0005499_abnormal_olfactory_system | 1.95762513 |
| 33 | MP0005394_taste/olfaction_phenotype | 1.95762513 |
| 34 | MP0003878_abnormal_ear_physiology | 1.93014553 |
| 35 | MP0005377_hearing/vestibular/ear_phenot | 1.93014553 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.92596286 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.91137669 |
| 38 | MP0003075_altered_response_to | 1.90172964 |
| 39 | MP0005451_abnormal_body_composition | 1.87598840 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.86942307 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.86244762 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.84634714 |
| 43 | MP0004510_myositis | 1.75744754 |
| 44 | MP0000343_altered_response_to | 1.74698952 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.71732272 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.70146608 |
| 47 | MP0009840_abnormal_foam_cell | 1.69789322 |
| 48 | MP0004270_analgesia | 1.68585815 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.65281877 |
| 50 | MP0004859_abnormal_synaptic_plasticity | 1.64943274 |
| 51 | MP0005365_abnormal_bile_salt | 1.63912689 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.63224307 |
| 53 | MP0008469_abnormal_protein_level | 1.63214628 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.60372576 |
| 55 | MP0001905_abnormal_dopamine_level | 1.59674621 |
| 56 | MP0000678_abnormal_parathyroid_gland | 1.58698680 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53449357 |
| 58 | MP0002734_abnormal_mechanical_nocicepti | 1.52225523 |
| 59 | MP0001756_abnormal_urination | 1.49472804 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.48022876 |
| 61 | MP0002822_catalepsy | 1.46343914 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 1.45929123 |
| 63 | MP0005166_decreased_susceptibility_to | 1.45806105 |
| 64 | MP0000604_amyloidosis | 1.45615868 |
| 65 | MP0002136_abnormal_kidney_physiology | 1.45263634 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.44291134 |
| 67 | MP0004947_skin_inflammation | 1.43007388 |
| 68 | MP0000751_myopathy | 1.41643778 |
| 69 | MP0001790_abnormal_immune_system | 1.41588845 |
| 70 | MP0005387_immune_system_phenotype | 1.41588845 |
| 71 | MP0005535_abnormal_body_temperature | 1.39100266 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.38568235 |
| 73 | MP0001765_abnormal_ion_homeostasis | 1.37300869 |
| 74 | MP0001853_heart_inflammation | 1.35606982 |
| 75 | MP0003123_paternal_imprinting | 1.33786241 |
| 76 | MP0003252_abnormal_bile_duct | 1.31510284 |
| 77 | MP0002452_abnormal_antigen_presenting | 1.29267711 |
| 78 | MP0005083_abnormal_biliary_tract | 1.25739528 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.25635738 |
| 80 | MP0010329_abnormal_lipoprotein_level | 1.24646556 |
| 81 | MP0002723_abnormal_immune_serum | 1.23699966 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.22263066 |
| 83 | MP0004858_abnormal_nervous_system | 1.19535377 |
| 84 | MP0001958_emphysema | 1.17348031 |
| 85 | MP0004130_abnormal_muscle_cell | 1.15797359 |
| 86 | MP0003172_abnormal_lysosome_physiology | 1.15238678 |
| 87 | MP0003879_abnormal_hair_cell | 1.14552353 |
| 88 | MP0004147_increased_porphyrin_level | 1.14397282 |
| 89 | MP0000685_abnormal_immune_system | 1.12713340 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 1.10159106 |
| 91 | MP0005330_cardiomyopathy | 1.09245660 |
| 92 | MP0000681_abnormal_thyroid_gland | 1.08184111 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 1.05973144 |
| 94 | MP0001529_abnormal_vocalization | 1.05929781 |
| 95 | MP0005501_abnormal_skin_physiology | 1.05468313 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 1.05147661 |
| 97 | MP0001849_ear_inflammation | 1.04525091 |
| 98 | MP0001819_abnormal_immune_cell | 1.02786281 |
| 99 | MP0005164_abnormal_response_to | 1.01799164 |
| 100 | MP0000579_abnormal_nail_morphology | 1.01671240 |
| 101 | MP0001800_abnormal_humoral_immune | 1.01346466 |
| 102 | MP0002876_abnormal_thyroid_physiology | 1.01083351 |
| 103 | MP0000467_abnormal_esophagus_morphology | 1.00218782 |
| 104 | MP0002796_impaired_skin_barrier | 1.00065985 |
| 105 | MP0002420_abnormal_adaptive_immunity | 0.99370497 |
| 106 | MP0000609_abnormal_liver_physiology | 0.98288371 |
| 107 | MP0002282_abnormal_trachea_morphology | 0.97911940 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.96324169 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.95927508 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.94947206 |
| 111 | MP0003329_amyloid_beta_deposits | 0.94332154 |
| 112 | MP0000358_abnormal_cell_content/ | 0.94108887 |
| 113 | MP0000858_altered_metastatic_potential | 0.93788449 |
| 114 | MP0001346_abnormal_lacrimal_gland | 0.90988365 |
| 115 | MP0005671_abnormal_response_to | 0.90734320 |
| 116 | MP0002006_tumorigenesis | 0.90044479 |
| 117 | MP0001970_abnormal_pain_threshold | 0.89529228 |
| 118 | MP0009763_increased_sensitivity_to | 0.88039270 |
| 119 | MP0005165_increased_susceptibility_to | 0.87680868 |
| 120 | MP0001727_abnormal_embryo_implantation | 0.87635987 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.87483500 |
| 122 | MP0000538_abnormal_urinary_bladder | 0.87228123 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.86684211 |
| 124 | MP0002405_respiratory_system_inflammati | 0.86459549 |
| 125 | MP0005670_abnormal_white_adipose | 0.86326208 |
| 126 | MP0001764_abnormal_homeostasis | 0.84543126 |
| 127 | MP0003448_altered_tumor_morphology | 0.84382688 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.84037173 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.82943911 |
| 130 | MP0010771_integument_phenotype | 0.82672963 |
| 131 | MP0003122_maternal_imprinting | 0.82236314 |
| 132 | MP0003011_delayed_dark_adaptation | 0.81540738 |
| 133 | MP0001666_abnormal_nutrient_absorption | 0.81223993 |
| 134 | MP0010386_abnormal_urinary_bladder | 0.80948695 |
| 135 | MP0004272_abnormal_basement_membrane | 0.80520242 |
| 136 | MP0008260_abnormal_autophagy | 0.78057866 |
| 137 | MP0003690_abnormal_glial_cell | 0.77920151 |
| 138 | MP0003283_abnormal_digestive_organ | 0.77207324 |
| 139 | MP0000762_abnormal_tongue_morphology | 0.77100927 |
| 140 | MP0009642_abnormal_blood_homeostasis | 0.76471242 |
| 141 | MP0003828_pulmonary_edema | 0.75321198 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.74253521 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.73699040 |
| 144 | MP0002098_abnormal_vibrissa_morphology | 0.72688911 |
| 145 | MP0002160_abnormal_reproductive_system | 0.72517201 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.72110999 |
| 147 | MP0002972_abnormal_cardiac_muscle | 0.72044123 |
| 148 | MP0005084_abnormal_gallbladder_morpholo | 0.71514145 |
| 149 | MP0009046_muscle_twitch | 0.71333147 |
| 150 | MP0005310_abnormal_salivary_gland | 0.70154195 |
| 151 | MP0008004_abnormal_stomach_pH | 0.69866057 |
| 152 | MP0001502_abnormal_circadian_rhythm | 0.69207726 |
| 153 | MP0005248_abnormal_Harderian_gland | 0.68567437 |
| 154 | MP0002060_abnormal_skin_morphology | 0.68555986 |
| 155 | MP0003705_abnormal_hypodermis_morpholog | 0.67450721 |
| 156 | MP0003566_abnormal_cell_adhesion | 0.67021892 |
| 157 | MP0000749_muscle_degeneration | 0.66808536 |
| 158 | MP0009278_abnormal_bone_marrow | 0.66678269 |
| 159 | MP0008872_abnormal_physiological_respon | 0.66392991 |
| 160 | MP0002736_abnormal_nociception_after | 0.65742502 |
| 161 | MP0002249_abnormal_larynx_morphology | 0.64251687 |
| 162 | MP0005257_abnormal_intraocular_pressure | 0.64101450 |
| 163 | MP0001944_abnormal_pancreas_morphology | 0.63848799 |
| 164 | MP0008775_abnormal_heart_ventricle | 0.63808945 |
| 165 | MP0005408_hypopigmentation | 0.63479823 |
| 166 | MP0002557_abnormal_social/conspecific_i | 0.61875199 |
| 167 | MP0001299_abnormal_eye_distance/ | 0.60918478 |
| 168 | MP0000747_muscle_weakness | 0.59081465 |
| 169 | MP0000026_abnormal_inner_ear | 0.59079723 |
| 170 | MP0003634_abnormal_glial_cell | 0.58853839 |
| 171 | MP0002295_abnormal_pulmonary_circulatio | 0.58652550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal respiratory motile cilium morphology (HP:0005938) | 9.37018395 |
| 2 | Abnormal respiratory epithelium morphology (HP:0012253) | 9.37018395 |
| 3 | Abnormal respiratory motile cilium physiology (HP:0012261) | 9.19238382 |
| 4 | Abnormal ciliary motility (HP:0012262) | 8.82813896 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 8.63108922 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 8.63108922 |
| 7 | Rhinitis (HP:0012384) | 8.55742904 |
| 8 | Chronic bronchitis (HP:0004469) | 6.94836276 |
| 9 | Bronchiectasis (HP:0002110) | 5.96951346 |
| 10 | Nasal polyposis (HP:0100582) | 5.81092912 |
| 11 | Eczematoid dermatitis (HP:0000976) | 5.36853497 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.25655718 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 4.88328949 |
| 14 | Recurrent abscess formation (HP:0002722) | 4.84697991 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 4.67267515 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.95779001 |
| 17 | Male infertility (HP:0003251) | 3.69160532 |
| 18 | Infertility (HP:0000789) | 3.63983655 |
| 19 | Hypokalemic alkalosis (HP:0001949) | 3.61795151 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.59891098 |
| 21 | Axonal loss (HP:0003447) | 3.58007866 |
| 22 | Metabolic alkalosis (HP:0200114) | 3.56598235 |
| 23 | Gout (HP:0001997) | 3.55516059 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.55316602 |
| 25 | Hyperactive renin-angiotensin system (HP:0000841) | 3.52357915 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.37258428 |
| 27 | Recurrent sinusitis (HP:0011108) | 3.32581830 |
| 28 | Bronchitis (HP:0012387) | 3.23795570 |
| 29 | Recurrent otitis media (HP:0000403) | 3.20194403 |
| 30 | Increased circulating renin level (HP:0000848) | 3.18143823 |
| 31 | Abnormality of purine metabolism (HP:0004352) | 3.15767338 |
| 32 | Occipital encephalocele (HP:0002085) | 3.15487408 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.14795550 |
| 34 | Abnormality of chloride homeostasis (HP:0011422) | 3.13721731 |
| 35 | Atelectasis (HP:0100750) | 3.10295689 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 3.09878638 |
| 37 | Gingivitis (HP:0000230) | 3.06311413 |
| 38 | Polyuria (HP:0000103) | 3.03025918 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.97384825 |
| 40 | Chronic sinusitis (HP:0011109) | 2.96122092 |
| 41 | Hypomagnesemia (HP:0002917) | 2.93516215 |
| 42 | Proximal tubulopathy (HP:0000114) | 2.93136273 |
| 43 | Abnormal urine output (HP:0012590) | 2.92304057 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.87309327 |
| 45 | Hyperglycinuria (HP:0003108) | 2.85910152 |
| 46 | Alkalosis (HP:0001948) | 2.85665062 |
| 47 | Nausea (HP:0002018) | 2.78711106 |
| 48 | Abnormality of renal excretion (HP:0011036) | 2.77292371 |
| 49 | Abnormality of magnesium homeostasis (HP:0004921) | 2.76323025 |
| 50 | Hand muscle atrophy (HP:0009130) | 2.66143112 |
| 51 | Xanthomatosis (HP:0000991) | 2.64010139 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 2.62675629 |
| 53 | Hydroxyprolinuria (HP:0003080) | 2.62675629 |
| 54 | Urticaria (HP:0001025) | 2.62205003 |
| 55 | Increased purine levels (HP:0004368) | 2.61164753 |
| 56 | Hyperuricemia (HP:0002149) | 2.61164753 |
| 57 | Tetany (HP:0001281) | 2.59238209 |
| 58 | Recurrent skin infections (HP:0001581) | 2.58547100 |
| 59 | Ketoacidosis (HP:0001993) | 2.57280088 |
| 60 | Stomatitis (HP:0010280) | 2.54800511 |
| 61 | Joint hemorrhage (HP:0005261) | 2.47836024 |
| 62 | Ketosis (HP:0001946) | 2.46018424 |
| 63 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.46001418 |
| 64 | Obstructive lung disease (HP:0006536) | 2.45377183 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.45377183 |
| 66 | Neoplasm of head and neck (HP:0012288) | 2.44974884 |
| 67 | Esophageal neoplasm (HP:0100751) | 2.44974884 |
| 68 | Abnormality of nucleobase metabolism (HP:0010932) | 2.43966717 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.42540746 |
| 70 | Glycosuria (HP:0003076) | 2.42540746 |
| 71 | Hyperaldosteronism (HP:0000859) | 2.42041056 |
| 72 | Tetraparesis (HP:0002273) | 2.31897724 |
| 73 | Polydipsia (HP:0001959) | 2.30527177 |
| 74 | Abnormal drinking behavior (HP:0030082) | 2.30527177 |
| 75 | Pancreatic fibrosis (HP:0100732) | 2.30356138 |
| 76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.28088958 |
| 77 | Increased cerebral lipofuscin (HP:0011813) | 2.26815172 |
| 78 | True hermaphroditism (HP:0010459) | 2.25627755 |
| 79 | Distal upper limb amyotrophy (HP:0007149) | 2.25176904 |
| 80 | Upper limb amyotrophy (HP:0009129) | 2.25176904 |
| 81 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.24436877 |
| 82 | Abnormality of glycine metabolism (HP:0010895) | 2.24436877 |
| 83 | Renal salt wasting (HP:0000127) | 2.22768052 |
| 84 | Hyperammonemia (HP:0001987) | 2.20282280 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.18781340 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14398125 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.14398125 |
| 88 | Abnormality of renin-angiotensin system (HP:0000847) | 2.13764627 |
| 89 | Distal lower limb muscle weakness (HP:0009053) | 2.13226360 |
| 90 | Vomiting (HP:0002013) | 2.12946761 |
| 91 | Acute encephalopathy (HP:0006846) | 2.09455757 |
| 92 | Conjunctival hamartoma (HP:0100780) | 2.08993208 |
| 93 | Hepatocellular necrosis (HP:0001404) | 2.08853861 |
| 94 | Glomerulonephritis (HP:0000099) | 2.08812320 |
| 95 | Vascular calcification (HP:0004934) | 2.07501174 |
| 96 | Cerebral edema (HP:0002181) | 2.07279377 |
| 97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06476632 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.03627705 |
| 99 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03340708 |
| 100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03340708 |
| 101 | Hypophosphatemia (HP:0002148) | 2.02428600 |
| 102 | Orchitis (HP:0100796) | 2.00252660 |
| 103 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 10.8046106 |
| 104 | Cystic liver disease (HP:0006706) | 1.99236293 |
| 105 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97868524 |
| 106 | Mitochondrial inheritance (HP:0001427) | 1.96629922 |
| 107 | Hyperphosphaturia (HP:0003109) | 1.95274464 |
| 108 | Myositis (HP:0100614) | 1.95062328 |
| 109 | Nephritis (HP:0000123) | 1.94692734 |
| 110 | Metabolic acidosis (HP:0001942) | 1.94511538 |
| 111 | Renal tubular acidosis (HP:0001947) | 1.94415506 |
| 112 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89978317 |
| 113 | Mucopolysacchariduria (HP:0008155) | 1.89978317 |
| 114 | Bell-shaped thorax (HP:0001591) | 1.87249182 |
| 115 | Lethargy (HP:0001254) | 1.87240460 |
| 116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86549251 |
| 117 | Pustule (HP:0200039) | 1.86150796 |
| 118 | Sensorimotor neuropathy (HP:0007141) | 1.85925382 |
| 119 | Cardiovascular calcification (HP:0011915) | 1.84936488 |
| 120 | Recurrent fungal infections (HP:0002841) | 1.84918882 |
| 121 | Chronic otitis media (HP:0000389) | 1.84590396 |
| 122 | Hepatic necrosis (HP:0002605) | 1.82916039 |
| 123 | Complement deficiency (HP:0004431) | 1.82433098 |
| 124 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80343437 |
| 125 | Limb-girdle muscle atrophy (HP:0003797) | 1.80299677 |
| 126 | Myokymia (HP:0002411) | 1.79837230 |
| 127 | Abnormal urine phosphate concentration (HP:0012599) | 1.78136137 |
| 128 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.77725469 |
| 129 | Molar tooth sign on MRI (HP:0002419) | 1.76907312 |
| 130 | Abnormality of midbrain morphology (HP:0002418) | 1.76907312 |
| 131 | Myocardial infarction (HP:0001658) | 1.76035525 |
| 132 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.75278782 |
| 133 | Postaxial foot polydactyly (HP:0001830) | 1.74901604 |
| 134 | Acute necrotizing encephalopathy (HP:0006965) | 1.73583065 |
| 135 | Amyloidosis (HP:0011034) | 1.73318856 |
| 136 | Thick nail (HP:0001805) | 1.72674891 |
| 137 | Bone cyst (HP:0012062) | 1.72363305 |
| 138 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71858061 |
| 139 | Growth hormone excess (HP:0000845) | 1.70583376 |
| 140 | Abnormal gallbladder physiology (HP:0012438) | 1.70569271 |
| 141 | Cholecystitis (HP:0001082) | 1.70569271 |
| 142 | Progressive macrocephaly (HP:0004481) | 1.70333111 |
| 143 | Stridor (HP:0010307) | 1.65444314 |
| 144 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.65196849 |
| 145 | Hyponatremia (HP:0002902) | 1.64958681 |
| 146 | Abnormality of dentin (HP:0010299) | 1.64926257 |
| 147 | Exercise intolerance (HP:0003546) | 1.63199532 |
| 148 | Nephronophthisis (HP:0000090) | 1.56945182 |
| 149 | Increased CSF lactate (HP:0002490) | 1.55533521 |
| 150 | Pancreatic cysts (HP:0001737) | 1.53973037 |
| 151 | Medial flaring of the eyebrow (HP:0010747) | 1.53430572 |
| 152 | Gait imbalance (HP:0002141) | 1.51763946 |
| 153 | Increased intramyocellular lipid droplets (HP:0012240) | 1.49779920 |
| 154 | Decreased circulating renin level (HP:0003351) | 1.47725655 |
| 155 | Nephropathy (HP:0000112) | 1.47472103 |
| 156 | Congenital primary aphakia (HP:0007707) | 1.46334724 |
| 157 | Glucose intolerance (HP:0000833) | 1.44898193 |
| 158 | Respiratory failure (HP:0002878) | 1.43784818 |
| 159 | Diaphragmatic weakness (HP:0009113) | 1.42893421 |
| 160 | Fetal akinesia sequence (HP:0001989) | 1.41942447 |
| 161 | Spinal cord compression (HP:0002176) | 1.40686848 |
| 162 | Sclerocornea (HP:0000647) | 1.39988467 |
| 163 | Male pseudohermaphroditism (HP:0000037) | 1.39165657 |
| 164 | Rough bone trabeculation (HP:0100670) | 1.39147109 |
| 165 | Craniofacial dystonia (HP:0012179) | 1.38968737 |
| 166 | Short nail (HP:0001799) | 1.37964837 |
| 167 | Aplasia of the musculature (HP:0100854) | 1.36992055 |
| 168 | Popliteal pterygium (HP:0009756) | 1.36727788 |
| 169 | Focal dystonia (HP:0004373) | 1.35745927 |
| 170 | Increased muscle lipid content (HP:0009058) | 1.34830530 |
| 171 | Torticollis (HP:0000473) | 1.32890371 |
| 172 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.32784934 |
| 173 | Nuclear cataract (HP:0100018) | 1.31921185 |
| 174 | Abnormality of glycolysis (HP:0004366) | 1.29532422 |
| 175 | Anencephaly (HP:0002323) | 1.28870378 |
| 176 | Nephrogenic diabetes insipidus (HP:0009806) | 1.27041765 |
| 177 | Abnormality of sodium homeostasis (HP:0010931) | 1.26070983 |
| 178 | Renal Fanconi syndrome (HP:0001994) | 1.25500694 |
| 179 | Congenital hepatic fibrosis (HP:0002612) | 1.25024436 |
| 180 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.24347516 |
| 181 | Hypokinesia (HP:0002375) | 1.23164106 |
| 182 | Increased serum pyruvate (HP:0003542) | 1.21259668 |
| 183 | Testicular atrophy (HP:0000029) | 1.20120761 |
| 184 | Furrowed tongue (HP:0000221) | 1.19744610 |
| 185 | Asplenia (HP:0001746) | 1.19461463 |
| 186 | Myopathic facies (HP:0002058) | 1.18430408 |
| 187 | Oculomotor apraxia (HP:0000657) | 1.17125514 |
| 188 | Hypotension (HP:0002615) | 1.17050386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.25624756 |
| 2 | MAPK15 | 4.99211133 |
| 3 | RIPK4 | 4.76976492 |
| 4 | BLK | 3.00402072 |
| 5 | ERN1 | 2.84791139 |
| 6 | MAP3K14 | 2.79625999 |
| 7 | WNK4 | 2.77716848 |
| 8 | WNK3 | 2.74695282 |
| 9 | NME1 | 2.72264891 |
| 10 | LIMK1 | 2.70796393 |
| 11 | VRK2 | 2.63928876 |
| 12 | TBK1 | 2.52101944 |
| 13 | IRAK3 | 2.45813438 |
| 14 | MAP3K12 | 2.35768525 |
| 15 | TESK2 | 2.35266090 |
| 16 | PBK | 2.26426762 |
| 17 | BCKDK | 2.19265780 |
| 18 | MST1R | 2.13186374 |
| 19 | IRAK4 | 2.08578668 |
| 20 | OXSR1 | 2.05900522 |
| 21 | STK16 | 1.84158179 |
| 22 | TYK2 | 1.80672971 |
| 23 | ARAF | 1.80539340 |
| 24 | PIM2 | 1.70893665 |
| 25 | TRIB3 | 1.62654206 |
| 26 | NME2 | 1.62140195 |
| 27 | IKBKE | 1.57619024 |
| 28 | PAK4 | 1.55030645 |
| 29 | SMG1 | 1.54092682 |
| 30 | ABL2 | 1.52901210 |
| 31 | MYLK | 1.51505537 |
| 32 | MAP3K11 | 1.30920547 |
| 33 | MAP2K7 | 1.29651299 |
| 34 | PDK2 | 1.28368204 |
| 35 | ILK | 1.27665362 |
| 36 | FGR | 1.22504113 |
| 37 | JAK1 | 1.22425596 |
| 38 | NTRK1 | 1.20391999 |
| 39 | PRKCI | 1.19913704 |
| 40 | MST4 | 1.19429279 |
| 41 | PDK3 | 1.18548431 |
| 42 | PDK4 | 1.18548431 |
| 43 | TTN | 1.17485814 |
| 44 | CSK | 1.16281728 |
| 45 | PHKG1 | 1.13784342 |
| 46 | PHKG2 | 1.13784342 |
| 47 | MAP3K13 | 1.12869696 |
| 48 | CAMK2G | 1.10349603 |
| 49 | FGFR4 | 1.09938355 |
| 50 | GRK5 | 1.08059193 |
| 51 | NEK9 | 1.05014879 |
| 52 | TESK1 | 1.04681045 |
| 53 | KDR | 1.04505248 |
| 54 | IKBKB | 1.04243608 |
| 55 | GRK7 | 1.03782934 |
| 56 | BCR | 1.01547441 |
| 57 | RIPK1 | 1.01398012 |
| 58 | EPHB2 | 0.96694718 |
| 59 | MAP3K5 | 0.95383427 |
| 60 | KIT | 0.94221646 |
| 61 | SYK | 0.93628138 |
| 62 | KSR2 | 0.93114216 |
| 63 | PDPK1 | 0.92996037 |
| 64 | BMX | 0.90449857 |
| 65 | JAK2 | 0.88207824 |
| 66 | MAP4K1 | 0.85092263 |
| 67 | EPHB1 | 0.83821636 |
| 68 | DAPK2 | 0.83752225 |
| 69 | MAP3K3 | 0.82562416 |
| 70 | MAP3K1 | 0.82313423 |
| 71 | MET | 0.80688119 |
| 72 | AURKA | 0.80086467 |
| 73 | BMPR2 | 0.79038332 |
| 74 | TXK | 0.78406250 |
| 75 | PTK2 | 0.78098792 |
| 76 | PRKCD | 0.78022889 |
| 77 | ZAP70 | 0.77332727 |
| 78 | LRRK2 | 0.76990713 |
| 79 | PINK1 | 0.75769794 |
| 80 | MUSK | 0.75535694 |
| 81 | GRK6 | 0.75490290 |
| 82 | CDK19 | 0.75142602 |
| 83 | JAK3 | 0.73145944 |
| 84 | PRKD3 | 0.72412101 |
| 85 | DAPK3 | 0.72286946 |
| 86 | MAP2K3 | 0.70573056 |
| 87 | HCK | 0.70067803 |
| 88 | CSNK1G3 | 0.69174539 |
| 89 | PTK2B | 0.69098690 |
| 90 | PDK1 | 0.68432112 |
| 91 | PAK1 | 0.67860710 |
| 92 | DYRK2 | 0.67720144 |
| 93 | ROCK2 | 0.65997888 |
| 94 | TRPM7 | 0.65057014 |
| 95 | LMTK2 | 0.64012635 |
| 96 | PIK3CG | 0.62382270 |
| 97 | BRAF | 0.61766589 |
| 98 | MATK | 0.61354940 |
| 99 | MAP3K2 | 0.60688398 |
| 100 | EPHA4 | 0.60629928 |
| 101 | FER | 0.60267424 |
| 102 | AKT2 | 0.59766988 |
| 103 | TTK | 0.59690803 |
| 104 | ERBB4 | 0.59550830 |
| 105 | FES | 0.59128868 |
| 106 | LYN | 0.58055826 |
| 107 | MAP2K4 | 0.57766683 |
| 108 | TAOK1 | 0.56802053 |
| 109 | CSNK1G2 | 0.55609928 |
| 110 | STK38L | 0.52876489 |
| 111 | MARK3 | 0.52745013 |
| 112 | EIF2AK1 | 0.51695954 |
| 113 | IRAK1 | 0.50236669 |
| 114 | PRKG2 | 0.49917974 |
| 115 | MINK1 | 0.49839953 |
| 116 | PKN2 | 0.49773125 |
| 117 | MAP2K2 | 0.49543975 |
| 118 | ROCK1 | 0.48763213 |
| 119 | TAOK2 | 0.48713227 |
| 120 | STK38 | 0.48405628 |
| 121 | CAMK2D | 0.47676714 |
| 122 | MAP3K9 | 0.46113482 |
| 123 | DYRK1B | 0.44498985 |
| 124 | NEK1 | 0.44038084 |
| 125 | MARK2 | 0.43614964 |
| 126 | MAP2K1 | 0.42979571 |
| 127 | LATS2 | 0.42587771 |
| 128 | SIK3 | 0.41944711 |
| 129 | EGFR | 0.41199452 |
| 130 | BTK | 0.41122109 |
| 131 | PIM1 | 0.40168202 |
| 132 | MAP2K6 | 0.39797351 |
| 133 | MAPKAPK3 | 0.39218324 |
| 134 | PTK6 | 0.38813454 |
| 135 | STK24 | 0.37997502 |
| 136 | CSNK1A1L | 0.37673314 |
| 137 | ADRBK1 | 0.37632562 |
| 138 | EEF2K | 0.37609289 |
| 139 | PRKCZ | 0.36811442 |
| 140 | MAPK4 | 0.36405646 |
| 141 | DAPK1 | 0.35996522 |
| 142 | CAMK2B | 0.35658475 |
| 143 | MAPK12 | 0.35539431 |
| 144 | MAPK11 | 0.35528123 |
| 145 | IRAK2 | 0.35461523 |
| 146 | STK39 | 0.34909640 |
| 147 | PAK6 | 0.34437733 |
| 148 | ABL1 | 0.33555794 |
| 149 | PRKACG | 0.33224349 |
| 150 | TGFBR2 | 0.32408018 |
| 151 | CAMK2A | 0.31876958 |
| 152 | TLK1 | 0.31848195 |
| 153 | PRKD2 | 0.31454700 |
| 154 | PRKD1 | 0.29065564 |
| 155 | ICK | 0.28205643 |
| 156 | PRKCA | 0.27906370 |
| 157 | CSNK1G1 | 0.27504524 |
| 158 | UHMK1 | 0.26529296 |
| 159 | STK10 | 0.25808831 |
| 160 | RPS6KB2 | 0.25288064 |
| 161 | SIK1 | 0.25261683 |
| 162 | MARK1 | 0.24866256 |
| 163 | CDK14 | 0.24461742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 2.68353754 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67590915 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.59746581 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.33833328 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.04782633 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98362162 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.97972374 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.97818086 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86324038 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.83462337 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82089504 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81578842 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.78204376 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77788086 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76585241 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.71348246 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.69683009 |
| 18 | * Peroxisome_Homo sapiens_hsa04146 | 1.67980161 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.65580387 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.59801674 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56828291 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.52971027 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52485015 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.48228911 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46399077 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.46187395 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.44740074 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.43199077 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41198652 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36746647 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35500499 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33270340 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.32963280 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32319839 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30658970 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.29619777 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29391480 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24193510 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24016115 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22879363 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.16828115 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16424203 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.15762487 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14078331 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11668189 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11600675 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.10011412 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.06643937 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06014957 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03805842 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.03640348 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02853962 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01687518 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.99371421 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99340869 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97320994 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96152261 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95946690 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93221691 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.91849892 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91108187 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.90853024 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90621887 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89477830 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89178346 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.88897641 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86912231 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86644641 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85584494 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84651453 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84643794 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84462615 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84270464 |
| 74 | Tight junction_Homo sapiens_hsa04530 | 0.84244432 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.84155667 |
| 76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.81299821 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81214591 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78543191 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76977475 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76556699 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76390020 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75895911 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75345252 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74392810 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72963309 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.69983760 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69929351 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68866563 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67961428 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65899961 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65831670 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65495598 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64655457 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63238242 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62730210 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.61046766 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60467984 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60042665 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59868181 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59261536 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57452990 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56129283 |
| 103 | Influenza A_Homo sapiens_hsa05164 | 0.55551935 |
| 104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53099861 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52702716 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52697839 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52414272 |
| 108 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51993458 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51577272 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51307290 |
| 111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51245199 |
| 112 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.48716418 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48700938 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.48181527 |
| 115 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47006080 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46913004 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46140943 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45919705 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45895364 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45261603 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44429096 |
| 122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43038101 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42489965 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.42089561 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41443698 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40791913 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40250631 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40124510 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40020626 |
| 130 | Measles_Homo sapiens_hsa05162 | 0.39492174 |
| 131 | Salivary secretion_Homo sapiens_hsa04970 | 0.37105732 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36392725 |
| 133 | RNA polymerase_Homo sapiens_hsa03020 | 0.35254832 |
| 134 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34801213 |
| 135 | Base excision repair_Homo sapiens_hsa03410 | 0.29929740 |
| 136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29006349 |
| 137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28642722 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.27483255 |

